Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Galassi

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Clinical Kidney Journal|October 2, 2023
The open system of FGF-23 at the crossroad between additional P-lowering therapy, anemia and inflammation: how to deal with the intact and the C-terminal assays?Lorenza Magagnoli, Mario Cozzolino, Andrea Galassi
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 11, 2022
Beyond vessels and bones: can CKD-MBD treatment improve uraemic subjects' minds?Lorenza Magagnoli, Andrea Galassi, Mario Cozzolino
Annals of Translational Medicine|March 26, 2019
Hyperphosphatemia: a novel risk factor for mortality in chronic kidney diseaseMario Cozzolino, Paola Ciceri, Andrea Galassi
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 8, 2023
[Extended release calcifediol and paricalcitol in the treatment of secondary hyperparathyroidism: a network meta-analysis of indirect comparison]Matteo Franchi, Andrea Galassi, Giovanni Corrao
Journal of Nephrology|July 26, 2011
What would we like to know, and what do we not know about fibroblast growth factor 23?Mario Cozzolino, Andrea Galassi, Mugurel Apetrii, et al.
Current Vascular Pharmacology|April 9, 2008
Pathogenesis and treatment of secondary hyperparathyroidism in dialysis patients: the role of paricalcitolMario Cozzolino, Andrea Galassi, Maurizio Gallieni, et al.
Journal of Nephrology|June 29, 2013
Cardiac valve calcification: an immutable pathologic finding in chronic kidney disease?Antonio Bellasi, Andrea Galassi, Sergio Papagni, et al.
Contributions to Nephrology|May 24, 2017
Phosphate in Chronic Kidney Disease ProgressionMario Cozzolino, Denis Foque, Paola Ciceri, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 7, 2017
[CKD-MBD, cardiovascular involvement and prognosis]Antonio Bellasi, Michela Mangano, Andrea Galassi, et al.
Forensic Science International|October 18, 2020
Men at war, recovery and analysis of soldiers' remains from the WWI and WWII Italian FrontDaniel Gaudio, Cristina Cattaneo, Andrea Galassi, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Clinical Kidney Journal|October 2, 2023
The open system of FGF-23 at the crossroad between additional P-lowering therapy, anemia and inflammation: how to deal with the intact and the C-terminal assays?Lorenza Magagnoli, Mario Cozzolino, Andrea Galassi
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 11, 2022
Beyond vessels and bones: can CKD-MBD treatment improve uraemic subjects' minds?Lorenza Magagnoli, Andrea Galassi, Mario Cozzolino
Annals of Translational Medicine|March 26, 2019
Hyperphosphatemia: a novel risk factor for mortality in chronic kidney diseaseMario Cozzolino, Paola Ciceri, Andrea Galassi
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 8, 2023
[Extended release calcifediol and paricalcitol in the treatment of secondary hyperparathyroidism: a network meta-analysis of indirect comparison]Matteo Franchi, Andrea Galassi, Giovanni Corrao
Journal of Nephrology|July 26, 2011
What would we like to know, and what do we not know about fibroblast growth factor 23?Mario Cozzolino, Andrea Galassi, Mugurel Apetrii, et al.
Current Vascular Pharmacology|April 9, 2008
Pathogenesis and treatment of secondary hyperparathyroidism in dialysis patients: the role of paricalcitolMario Cozzolino, Andrea Galassi, Maurizio Gallieni, et al.
Journal of Nephrology|June 29, 2013
Cardiac valve calcification: an immutable pathologic finding in chronic kidney disease?Antonio Bellasi, Andrea Galassi, Sergio Papagni, et al.
Contributions to Nephrology|May 24, 2017
Phosphate in Chronic Kidney Disease ProgressionMario Cozzolino, Denis Foque, Paola Ciceri, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 7, 2017
[CKD-MBD, cardiovascular involvement and prognosis]Antonio Bellasi, Michela Mangano, Andrea Galassi, et al.
Forensic Science International|October 18, 2020
Men at war, recovery and analysis of soldiers' remains from the WWI and WWII Italian FrontDaniel Gaudio, Cristina Cattaneo, Andrea Galassi, et al.
Pageof 11